Why Serum Magnesium Fails: A Narrative Review of Magnesium Biochemistry, Compartmental Exchange, and Endpoint Selection for Supplementation Trials
Abstract
Magnesium is an obligate cofactor in more than 600 enzymatic reactions, yet population-level inadequacy is widespread and rarely detected. The reason is largely methodological. Serum magnesium, used in routine care and in most supplementation trials, holds less than one percent of total body magnesium and is homeostatically defended by renal reabsorption and bone exchange, so individuals with substantial tissue depletion may present with values inside the reference range. This narrative review addresses a specific problem: the biochemical endpoints of oral magnesium supplementation trials are poorly matched to the compartments in which magnesium acts. The mismatch has attenuated the evidence in five clinical areas-essential hypertension, insulin resistance and type 2 diabetes, insomnia and disordered sleep, skeletal muscle cramping, and migraine prophylaxis-in each of which clinical benefit is reported without commensurate serum change. The review first establishes the biochemistry of magnesium essentiality, identifying the enzyme classes for which Mg-ATP is the physiological substrate and the systems in which the free ion acts as a structural or gating element. It then proposes an integrated model in which absorption, renal handling, bone exchange and intracellular distribution operate on distinct timescales, from hours for renal conservation to months for bone. Against that model, serum, erythrocyte, ionized, urinary and loading-test measurements are appraised, and…
Read the paper
Related studies
- Bioactive Molecules Released in Food by Lactic Acid Bacteria: Encrypted Peptides and Biogenic Amines
- A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications
- Bioaccessibility and bioavailability of phenolic compounds
- The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development
- Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery
- Effects of the Mediterranean Diet on the Components of Metabolic Syndrome Concerning the Cardiometabolic Risk
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.